Get started
Author

Xinglinzi Tang

ORCID: 0009-0000-4543-1806
Observed ORCID: 0009-0000-4543-1806
OpenAlex ID: A5032464386
Tanshinone I improves TNBC chemosensitivity by suppressing late-phase autophagy through AKT/p38 MAPK signaling pathway
2024 · Xinglinzi Tang, Jiaqian Gong, et al. · Biomedicine & Pharmacotherapy · 18
A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer
2022 · Yue Zhong, Fu Peng, et al. · Frontiers in Oncology · 16
Chrysin Inhibits TAMs-Mediated Autophagy Activation via CDK1/ULK1 Pathway and Reverses TAMs-Mediated Growth-Promoting Effects in Non-Small Cell Lung Cancer
2024 · Xinglinzi Tang, Xiaoru Luo, et al. · Pharmaceuticals · 10
PDF
Quercetagitrin targets EIF3D to activate NCOA4-mediated ferritinophagy-dependent ferroptosis for the treatment of non-small cell lung cancer
2026 · Xinglinzi Tang, Feiyan Wu, et al. · Phytomedicine · 5
Super-enhancers in immune system regulation: mechanisms, pathological reprogramming, and therapeutic opportunities
2025 · Xin Lai, Caizhi Li, et al. · Frontiers in Immunology · 3
PDF
A system pharmacology framework to explore the therapeutic mechanism of Bushen-Yizhi formula against Alzheimer’s disease via integrating UPLC-Q-TOF-MS/MS, network analysis, machine learning and experimental validation
2026 · Jieqi Zhang, Huijuan Rao, et al. · BMC Complementary Medicine and Therapies
Patent Landscape and Technological Trajectory of Drug Delivery Systems for Overcoming Drug Resistance in Non-small Cell Lung Cancer
2026 · Feiyan Wu, Xinglinzi Tang, et al. · Recent Patents on Anti-Cancer Drug Discovery
Orcinol glucoside ameliorates pulmonary fibrosis by suppressing hyaluronic acid synthesis and macrophage M2 polarization via targeting hyaluronic acid synthase 2
2026 · Caizi Li, Xinglinzi Tang, et al. · International Journal of Molecular Medicine
Works count: 8
Citation count: 52
H-index: 4
I10-index: 3
Year
Topic
Type